Transcription of Public Assessment Report Decentralised Procedure ...
{{id}} {{{paragraph}}}
PAR sayanaject 104 mg suspension for injection UK/H/5497/001/DC 1 Public Assessment Report Decentralised Procedure sayanaject 104 mg suspension for injection (Medroxyprogesterone acetate ) Procedure No: UK/H/5497/001/DC UK Licence No: PL 00057/1498 Pfizer Limited PAR sayanaject 104 mg suspension for injection UK/H/5497/001/DC 2 LAY SUMMARY sayanaject 104 mg suspension for injection (medroxyprogesterone acetate , suspension for injection, 104 mg) This is a summary of the Public Assessment Report (PAR) for sayanaject 104 mg suspension for injection (PL 00057/1498; UK/H/5497/001/DC).
PAR Sayanaject 104 mg suspension for injection UK/H/5497/001/DC 2 LAY SUMMARY Sayanaject 104 mg suspension for injection (medroxyprogesterone acetate, suspension for injection, 104 mg)
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Chemical Resistance Chart, Propyl, Sulfur Measurement Handbook, Public Assessment Report Mutual Recognition, Public Assessment Report Mutual Recognition Procedure, For Automotive OEM Coatings & Plastic, For Automotive OEM Coatings & Plastic Coatings, Product List, Declaration & Acceptance of Dangerous Goods, POLYETHYLENE/CHEMICAL COMPATIBILITY GUIDE, Siloxanes - Consumption, Toxicity and Alternatives